Facial Rejuvenation Market | Coherent Market Insights

1
Coherent Marketing Insights

• Market Research Business Consulting Services

• https//www.coherentmarketinsights.com/

• Covid-19 Impact Tracker

2

• FACIAL REJUVENATION MARKET ANALYSIS
• Facial Rejuvenation Market, By Product Type
  (Topical Rejuvenation Products (Keratolytics,
  Moisturizers, Retinoids, Sunscreens, Hair
  Removals) Botulinum products, Dermal Fillers
  (Absorbable Dermal Fillers, Non Absorbable Dermal
  Fillers), Chemical Peels, Micro Abrasion,
  Equipments (Laser Based Equipments, Ultrasound
  Based Equipments), By End User (Hospitals,
  Dermatology Clinics), and by Regions (North
  America, Latin America, Europe, Asia Pacific,
  Middle East, and Africa) - Size, Share, Outlook,
  and Opportunity Analysis, 2019 - 2027

3

• Facial rejuvenation is a combination of cosmetic
  procedures that are used to restore youthful
  appearance to the human face. Surgical and/or
  non-surgical methods are used to achieve facial
  rejuvenation. Facial rejuvenation is used for the
  treatment of static wrinkles, freckles, dynamic
  wrinkles, vascular conditions, scars and wounds,
  and pigmentation.
• The global facial rejuvenation market is
  estimated to account for US 35,518.9 Mn in terms
  of value by the end of 2027.

4

• Global Facial Rejuvenation Market Drivers
• Early onset of ageing and growing geriatric
  population is expected to boost growth of the
  global facial rejuvenation market over the
  forecast period. For instance, according to the
  World Health Organization (WHO), worldwide
  geriatric population is expected to reach 2
  billion by 2050 compared to 900 million in 2015.
• High adoption of advanced facial rejuvenation
  products and increasing number of non-surgical
  aesthetic procedures is also expected to boost
  growth of the market. For instance, InMode MD
  Ltd. is conducting clinical trial for
  energy-based lower eyelid rejuvenation using its
  InMode AccuTite. The study is expected to be
  completed in 2021.
• North America region held dominant position in
  the global facial rejuvenation market in 2018,
  accounting for 39.4 share in terms of volume,
  followed by Europe.

5

• Figure 1. Global Facial Rejuvenation Market Value
  (US Mn), by Region, 2018

6
Global Facial Rejuvenation Market Restraints

• High cost of procedures may deter customers from
  repeat visits, especially in emerging economies,
  which is expected to hinder growth of the global
  facial rejuvenation market. The cost of a single
  ablative laser procedure may be around US 2,100
  and other facial rejuvenation procedures or
  treatments could carry a price tag, which is over
  50 more compared to normal facial or beauty
  treatments.
• Moreover, unavailability of reimbursement options
  for minimally invasive treatments and procedures
  in emerging economies is also expected to hamper
  growth of the market.

7
Market Opportunities

• Increasing demand for prescription drugs instead
  of over-the-counter cosmetic products for facial
  rejuvenation treatments and procedures is
  expected to offer lucrative growth opportunities
  for market players.
• The demand for botulinum neurotoxin type-A for
  reducing wrinkles in the upper-third portion of
  the face (triangle region) is high. However,
  there are a few major suppliers of botulinum
  products, which leads to preferential pricing of
  the product. Therefore, key players in the market
  can focus on manufacturing botulinum products to
  overcome its scarcity.

8
Global Facial Rejuvenation Market Competitive
Landscape

• Major players operating in the global facial
  rejuvenation market include, Merz Pharma, Anika
  Therapeutics, Inc., Lumenis, Galderma, Allergan
  (Actavis), Contura Ltd., Fibrocell Science, Inc.,
  and Revance Therapeutics.
• Global Facial Rejuvenation Market Key
  Developments
• Key players in the market are focused on
  establishing subsidiaries to expand their
  geographical presence. For instance, in October
  2019, InMode Ltd. completed the establishment of
  two new subsidiaries in Asia Pacific - InMode
  India and InMode Australia.
• In December 2019, Daewoong Pharmaceutical, a
  pharmaceutical company based in South Korea,
  received approval for its botulinum toxin
  product, Nabota, from The Ministry of Health in
  the UAE and Indonesias Badan Pengawas Obat dan
  Makanan

9

• Request Sample Report
• Request Customization
• Download PDF Brochure
• Talk to Analyst
• Referance https//www.coherentmarketinsights.com/
  market-insight/facial-rejuvenation-market-3189

10
About Us

• Coherent Market Insights is a global market
  intelligence and consulting organization focused
  on assisting our plethora of clients achieve
  transformational growth by helping them make
  critical business decisions. We are headquartered
  in India, having office at global financial
  capital in the U.S. Our client base includes
  players from across all business verticals in
  over 150 countries worldwide.
• What We ProvideCustomized Market Research
  AnalysisIndustry Analysis ServicesBusiness
  Consulting ServicesLong Term Engagement
  ModelCountry Specific Analysis

11
Contact Us

• Mr. Shah
• Coherent Market Insights Pvt. LTD.Coherent
  Market Insights 1001 4th Ave, 3200 Seattle, WA
  98154, U.S.Phone [phone]
• Email sales_at_coherentmarketinsights.com

12
Thank You

• Kindly Follow CMI Social Media Profiles for the
  latest Company Updates.
• Facebook
• Linkedin
• Twitter
• https//www.coherentmarketinsights.com/